Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Clinical Genitourinary Cancer|January 18, 2022
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial CarcinomaMehrad Adibi, Barrett McCormick, Minas P Economides, et al.Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Metastasis-directed radiotherapy for oligometastatic urothelial carcinoma of the bladder and upper tractPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.Research Square|April 25, 2024
Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic MappingBogdan Czerniak, Sangkyou Lee, Sung Yun Jung, et al.Environmental and Molecular Mutagenesis|December 16, 2014
Transcriptional profiling identifies physicochemical properties of nanomaterials that are determinants of the in vivo pulmonary responseSabina Halappanavar, Anne Thoustrup Saber, Nathalie Decan, et al.Clinical and Translational Radiation Oncology|October 15, 2024
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancerPatrick Carriere, Omar Alhalabi, Jianjun Gao, et al.Urology|April 18, 2025
Differential Outcomes in Bladder Cancer After Neoadjuvant Chemotherapy: An International Multi-Institutional Study Comparing Isolated Nodal Disease vs Persistent Muscle-Invasive DiseaseAndres M Acosta, Mohammed Saad, Alcides Chaux, et al.Cell Reports|April 27, 2024
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesisSangkyou Lee, Jolanta Bondaruk, Yishan Wang, et al.European Urology Oncology|October 13, 2023
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary TractOmar Alhalabi, Nathaniel Wilson, Lianchun Xiao, et al.Nature Communications|September 24, 2021
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapyGuangchun Han, Guoliang Yang, Dapeng Hao, et al.Advances in Anatomic Pathology|June 15, 2021
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial CancersEva Compérat, Mahul B Amin, Jonathan I Epstein, et al.Pageof 4